000 | 01250 a2200325 4500 | ||
---|---|---|---|
005 | 20250516104411.0 | ||
264 | 0 | _c20121220 | |
008 | 201212s 0 0 eng d | ||
022 | _a1179-1950 | ||
024 | 7 |
_a10.2165/11635690-000000000-00000 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aMurukesan, Vidhya | |
245 | 0 | 0 |
_aManaging post-transplant lymphoproliferative disorders in solid-organ transplant recipients: a review of immunosuppressant regimens. _h[electronic resource] |
260 |
_bDrugs _cAug 2012 |
||
300 |
_a1631-43 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Review | ||
650 | 0 | 4 | _aClinical Trials, Phase II as Topic |
650 | 0 | 4 | _aClinical Trials, Phase III as Topic |
650 | 0 | 4 | _aDrug Evaluation, Preclinical |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aImmunosuppressive Agents _xtherapeutic use |
650 | 0 | 4 |
_aLymphoproliferative Disorders _xdrug therapy |
650 | 0 | 4 | _aProspective Studies |
650 | 0 | 4 | _aRandomized Controlled Trials as Topic |
650 | 0 | 4 | _aRisk Factors |
650 | 0 | 4 |
_aTransplants _xadverse effects |
700 | 1 | _aMukherjee, Sandeep | |
773 | 0 |
_tDrugs _gvol. 72 _gno. 12 _gp. 1631-43 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.2165/11635690-000000000-00000 _zAvailable from publisher's website |
999 |
_c22002706 _d22002706 |